CVE Stock Cenovus Energy (CVE, $15.06) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 5, 2025

GET DAILY SIGNALS

Get AI intraday signals

CVE - Cenovus Energy

MACD signal

View

Odds of UP Trend

Price: $15.06

Daily change: +$0.08 (+0.53%)

Daily volume: 11.1M

Capitalization: $27.5B

Industry: Integrated Oil

CVE's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for CVE turned positive on February 05, 2025. Looking at past instances where CVE's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 10, 2025. You may want to consider a long position or call options on CVE as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CVE moved above its 50-day moving average on February 10, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CVE crossed bullishly above the 50-day moving average on February 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CVE advanced for three days, in of 337 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CVE broke above its upper Bollinger Band on February 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CVE entered a downward trend on February 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.800) is normal, around the industry mean (1.194). P/E Ratio (12.817) is within average values for comparable stocks, (24.146). CVE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (4.841). Dividend Yield (0.021) settles around the average of (0.111) among similar stocks. P/S Ratio (0.943) is also within normal values, averaging (0.975).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.